β-lactams against methicillin-resistant Staphylococcus aureus

Current Opinion in Pharmacology

Volumn 5, Issue 5 SPEC.ISS., 2005, Pages 479-489

  Guignard, Bertrand ^a   Entenza, José M ^a   Moreillon, Philippe ^a  

^a UNIVERSITY OF LAUSANNE   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

7 [2 (2 AMINO 4 THIAZOLYL) 2 (CYCLOPENTYLOXYIMINO)ACETAMIDO] 3 [(1 ETHOXYCARBONYLMETHYL 4 PYRIDINIO)THIOMETHYL] 2 OXAISOCEPHEM 4 CARBOXYLIC ACID; 7 [[(2 AMINO 5 CHLORO 4 THIAZOLYL)(HYDROXYIMINO)ACETYL]AMINO] 3 [[3 [[(2 AMINOETHYL)THIO]METHYL] 4 PYRIDINYL]THIO] 8 OXO 5 THIA 1 AZABICYCLO[4.2.0]OCT 2 ENE 2 CARBOXYLIC ACID; 7BETA [2 (5 AMINO 1,2,4 THIADIAZOL 3 YL) 2 ETHOXYIMINOACETAMIDO] 3 [(1 METHYLAMINOPROPYL 1H IMIDAZO[4,5 B]PYRIDINIUM 4 YL)METHYL] 3 CEPHEM 4 CARBOXYLIC ACID; AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; ANTIBIOTIC AGENT; BETA LACTAM ANTIBIOTIC; BMS 247243; CAB 175; CARBAPENEM DERIVATIVE; CB 181963; CEFAMANDOLE; CEFOSELIS; CEFTOBIPROLE; CEFTOBIPROLE MEDOCARIL; CEFTOPIBROLE MEDOCARIL; CEPHALOSPORIN DERIVATIVE; CEPHEM DERIVATIVE; CS 023; HABEKACIN; IMIPENEM; L 695256; LB 11058; METICILLIN; PENICILLIN BINDING PROTEIN 2A; PENICILLIN G; PENICILLINASE; SULTAMICILLIN; TOC 39; TOC 50; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; BACTERIAL CELL WALL; BACTERIAL ENDOCARDITIS; BACTERIAL GROWTH; BACTERIAL INFECTION; BINDING AFFINITY; CLINICAL TRIAL; DISEASE MODEL; DRUG DESIGN; DRUG STRUCTURE; DRUG TARGETING; ENZYME INHIBITION; GROWTH INHIBITION; HUMAN; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; RAT; REVIEW; SKIN INFECTION; SOFT TISSUE INFECTION; TREATMENT OUTCOME; URINARY TRACT INFECTION;

EID: 24344466955     PISSN: 14714892     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.coph.2005.06.002     Document Type: Review

References (71)

1. F.D. Lowy Staphylococcus aureus infections N Engl J Med 339 1998 520-532
2. M.M. Dinges P.M. Orwin P.M. Schlievert Exotoxins of Staphylococcus aureus Clin Microbiol Rev 13 2000 16-34
3. R.P. Novick Autoinduction and signal transduction in the regulation of staphylococcal virulence Mol Microbiol 48 2003 1429-1449
4. R.P. Novick P. Schlievert A. Ruzin Pathogenicity and resistance islands of staphylococci Microbes Infect 3 2001 585-594
5. T. Baba F. Takeuchi M. Kuroda H. Yuzawa K. Aoki A. Oguchi Y. Nagai N. Iwama K. Asano T. Naimi Genome and virulence determinants of high virulence community-acquired MRSA Lancet 359 2002 1819-1827
6. M. Kuroda T. Ohta I. Uchiyama T. Baba H. Yuzawa I. Kobayashi L. Cui A. Oguchi K. Aoki Y. Nagai Whole genome sequencing of meticillin-resistant Staphylococcus aureus Lancet 357 2001 1225-1240
7. Y. Katayama T. Ito K. Hiramatsu A new class of genetic element, staphylococcus cassette chromosome mec, encodes methicillin resistance in Staphylococcus aureus Antimicrob Agents Chemother 44 2000 1549-1555
8. H.F. Chambers B.J. Hartman A. Tomasz Increased amounts of a novel penicillin-binding protein in a strain of methicillin-resistant Staphylococcus aureus exposed to nafcillin J Clin Invest 76 1985 325-331
9. T. Ito K. Okuma X.X. Ma H. Yuzawa K. Hiramatsu Insights on antibiotic resistance of Staphylococcus aureus from its whole genome: Genomic island SCC Drug Resist Updat 6 2003 41-52
10. T. Ito Y. Katayama K. Asada N. Mori K. Tsutsumimoto C. Tiensasitorn K. Hiramatsu Structural comparison of three types of staphylococcal cassette chromosome mec integrated in the chromosome in methicillin-resistant Staphylococcus aureus Antimicrob Agents Chemother 45 2001 1323-1336
11. X.X. Ma T. Ito C. Tiensasitorn M. Jamklang P. Chongtrakool S. Boyle-Vavra R.S. Daum K. Hiramatsu Novel type of staphylococcal cassette chromosome mec identified in community-acquired methicillin-resistant Staphylococcus aureus strains Antimicrob Agents Chemother 46 2002 1147-1152
12. J.M. Ghuysen Molecular structures of penicillin-binding proteins and beta-lactamases Trends Microbiol 2 1994 372-380
13. C. Goffin J.M. Ghuysen Multimodular penicillin-binding proteins: An enigmatic family of orthologs and paralogs Microbiol Mol Biol Rev 62 1998 1079-1093
14. L.K. McDougal C. Thornsberry The role of beta-lactamase in staphylococcal resistance to penicillinase-resistant penicillins and cephalosporins J Clin Microbiol 23 1986 832-839
15. B.L. de Jonge A. Tomasz Abnormal peptidoglycan produced in a methicillin-resistant strain of Staphylococcus aureus grown in the presence of methicillin: Functional role for penicillin-binding protein 2A in cell wall synthesis Antimicrob Agents Chemother 37 1993 342-346
16. S. Rohrer B. Berger-Bachi FemABX peptidyl transferases: A link between branched-chain cell wall peptide formation and beta-lactam resistance in gram-positive cocci Antimicrob Agents Chemother 47 2003 837-846
17. A. Ornelas-Soares H. de Lencastre B. de Jonge D. Gage Y.S. Chang A. Tomasz The peptidoglycan composition of a Staphylococcus aureus mutant selected for reduced methicillin resistance J Biol Chem 268 1993 26268-26272
18. B. Berger-Bächi Expression of resistance to methicillin Trends Microbiol 2 1994 389-393
19. H. de Lencastre A. Tomasz Reassessment of the number of auxiliary genes essential for expression of high-level methicillin resistance in Staphylococcus aureus Antimicrob Agents Chemother 38 1994 2590-2598
20. M.G. Pinho H. de Lencastre A. Tomasz An acquired and a native penicillin-binding protein cooperate in building the cell wall of drug-resistant staphylococci Proc Natl Acad Sci USA 98 2001 10886-10891
21. M. Franciolli J. Bille M.P. Glauser P. Moreillon Beta-lactam resistance mechanisms of methicillin-resistant Staphylococcus aureus J Infect Dis 163 1991 514-523
22. L. Hirano A.S. Bayer Beta-Lactam-beta-lactamase-inhibitor combinations are active in experimental endocarditis caused by beta-lactamase-producing oxacillin-resistant staphylococci Antimicrob Agents Chemother 35 1991 685-690
23. H.F. Chambers In vitro and in vivo antistaphylococcal activities of L-695,256, a carbapenem with high affinity for the penicillin-binding protein PBP 2a Antimicrob Agents Chemother 39 1995 462-466
24. Y.A. Que J.M. Entenza P. Francioli P. Moreillon The impact of penicillinase on cefamandole treatment and prophylaxis of experimental endocarditis due to methicillin-resistant Staphylococcus aureus J Infect Dis 177 1998 146-154
25. M.T. Gillespie J.W. May R.A. Skurray Antibiotic resistance in Staphylococcus aureus isolated at an Australian hospital between 1946 and 1981 J Med Microbiol 19 1985 137-147
26. G.R. Nimmo J.M. Bell D. Mitchell I.B. Gosbell J.W. Pearman J.D. Turnidge Antimicrobial resistance in Staphylococcus aureus in Australian teaching hospitals, 1989-1999 Microb Drug Resist 9 2003 155-160
27. K. Hiramatsu N. Aritaka H. Hanaki S. Kawasaki Y. Hosoda S. Hori Y. Fukuchi I. Kobayashi Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycin Lancet 350 1997 1670-1673
28. M. Backo E. Gaenger A. Burkart Y.L. Chai A.S. Bayer Treatment of experimental staphylococcal endocarditis due to a strain with reduced susceptibility in vitro to vancomycin: Efficacy of ampicillin-sulbactam Antimicrob Agents Chemother 43 1999 2565-2568
29. D. Lim N.C. Strynadka Structural basis for the beta lactam resistance of PBP2a from methicillin-resistant Staphylococcus aureus Nat Struct Biol 9 2002 870-876
30. A. Tomasz 'Intelligence coup' for drug designers: Crystal structure of Staphylococcus aureus beta-lactam resistance protein PBP2A Lancet 361 2003 795-796
31. R.F. Frongillo L. Donati G. Federico P. Martino M. Moroni L. Ortona M. Palumbo B.M. Pasticci E. Pizzigallo G. Privitera Clinical comparative study on the activity of cefamandole in the treatment of serious staphylococcal infections caused by methicillin-susceptible and methicillin-resistant strains Antimicrob Agents Chemother 29 1986 789-796
32. M.H. Nicolas M.D. Kitzis A. Karim Stérilisation par 2 grammes d'Augmentin (R) des urines infectées à Staphylococcus aureus résistant à la méticilline Med Mal Infect 23 1993 82-94 [Title translation: Sterilization of urines infected with methicillin-resistant Staphylococcus aureus with 2 grams of amoxicillin-clavulante].
33. M. Andreoni P. Raillard E. Concia Y. Wang Sulbactam/ampicillin in the treatment of skin and soft-tissue infections due to methicillin-resistant staphylococci A pilot study Current Therapeutic Research 50 1991 386-395
34. K. Hiramatsu H. Hanaki T. Ino K. Yabuta T. Oguri F.C. Tenover Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility J Antimicrob Chemother 40 1997 135-136
35. S. Chang D.M. Sievert J.C. Hageman M.L. Boulton F.C. Tenover F.P. Downes S. Shah J.T. Rudrik G.R. Pupp W.J. Brown Infection with vancomycin-resistant Staphylococcus aureus containing the vanA resistance gene N Engl J Med 348 2003 1342-1347
36. T.W. Glinka Novel cephalosporins for the treatment of MRSA infections Curr Opin Investig Drugs 3 2002 206-217
37. J.C. Fung-Tomc J. Clark B. Minassian M. Pucci Y.H. Tsai E. Gradelski L. Lamb I. Medina E. Huczko B. Kolek In vitro and in vivo activities of a novel cephalosporin, BMS-247243, against methicillin-resistant and -susceptible staphylococci Antimicrob Agents Chemother 46 2002 971-976
38. A. Cho T.W. Glinka M. Ludwikow A.T. Fan M. Wang S.J. Hecker New anti-MRSA cephalosporins with a basic aminopyridine at the C-7 position Bioorg Med Chem Lett 11 2001 137-140
39. T. Glinka K. Huie A. Cho M. Ludwikow J. Blais D. Griffith S. Hecker M. Dudley Relationships between structure, antibacterial activity, serum stability, pharmacokinetics and efficacy in 3-(heteroarylthio)cephems. Discovery of RWJ-333441 (MC-04,546) Bioorg Med Chem 11 2003 591-600
40. P. Hebeisen I. Heinze-Krauss P. Angehrn P. Hohl M.G. Page R.L. Then In vitro and in vivo properties of Ro 63-9141, a novel broad-spectrum cephalosporin with activity against methicillin-resistant staphylococci Antimicrob Agents Chemother 45 2001 825-836
41. D.C. Griffith L. Harford R. Williams V.J. Lee M.N. Dudley In vivo antibacterial activity of RWJ-54428, a new cephalosporin with activity against gram-positive bacteria Antimicrob Agents Chemother 47 2003 43-47
42. M. Tsuji M. Takema H. Miwa J. Shimada S. Kuwahara In vivo antibacterial activity of S-3578, a new broad-spectrum cephalosporin: Methicillin-resistant Staphylococcus aureus and Pseudomonas aeruginosa experimental infection models Antimicrob Agents Chemother 47 2003 2507-2512
43. M. Matsumoto H. Tamaoka H. Ishikawa M. Kikuchi In vitro and in vivo antibacterial activities of OPC-20011, a novel parenteral broad-spectrum 2-oxaisocephem antibiotic Antimicrob Agents Chemother 42 1998 2943-2949
44. Y. Mine Y. Watanabe H. Sakamoto K. Hatano K. Kuno T. Kamimura S. Tawara Y. Matsumoto F. Matsumoto S. Kuwahara Excellent activity of FK037, a novel parenteral broad-spectrum cephalosporin, against methicillin-resistant staphylococci J Antibiot (Tokyo) 46 1993 99-119
45. J.M. Entenza P. Hohl I. Heinze-Krauss M.P. Glauser P. Moreillon BAL9141, a novel extended-spectrum cephalosporin active against methicillin-resistant Staphylococcus aureus in treatment of experimental endocarditis Antimicrob Agents Chemother 46 2002 171-177
46. J. Vouillamoz J.M. Entenza P. Hohl P. Moreillon LB11058, a new cephalosporin with high penicillin-binding protein 2a affinity and activity in experimental endocarditis due to homogeneously methicillin-resistant Staphylococcus aureus Antimicrob Agents Chemother 48 2004 4322-4327
47. M.W. Climo S.M. Markowitz D.S. Williams C.G. Hale-Cooper G.L. Archer Comparison of the in-vitro and in-vivo efficacy of FK037, vancomycin, imipenem and nafcillin against staphylococcal species J Antimicrob Chemother 40 1997 59-66
48. H. Hanaki H. Akagi Y. Masaru T. Otani A. Hyodo K. Hiramatsu TOC-39, a novel parenteral broad-spectrum cephalosporin with excellent activity against methicillin-resistant Staphylococcus aureus Antimicrob Agents Chemother 39 1995 1120-1126
49. S. Nomura H. Hanaki N. Unemi In vitro antibacterial activity of TOC-50, a new parenteral cephalosporin against methicillin-resistant Staphylococcus aureus and Staphylococcus epidermidis Chemotherapy 42 1996 253-258
50. T.R. Anderegg R.N. Jones H.S. Sader Quality control guidelines for BAL9141 (Ro 63-9141), an investigational cephalosporin, when reference MIC and standardized disk diffusion susceptibility test methods are used J Clin Microbiol 42 2004 3356-3358
51. A. Watanabe Y. Tokue H. Takahashi T. Kikuchi T. Kobayashi K. Gomi S. Fujimura S. Yasui Y. Murayama T. Nukiwa Comparative in-vitro activity of carbapenem antibiotics against respiratory pathogens isolated between 1999 and 2000 J Infect Chemother 7 2001 267-271
52. P.H. Chandrasekar D.P. Levine S. Price M.J. Rybak Comparative efficacies of imipenem-cilastatin and vancomycin in experimental aortic valve endocarditis due to methicillin resistant Staphylococcus aureus J Antimicrob Chemother 21 1988 461-469
53. N. Ohtake H. Imamura H. Jona H. Kiyonaga A. Shimizu M. Moriya H. Sato M. Nakano R. Ushijima S. Nakagawa Novel dithiocarbamate carbapenems with anti-MRSA activity Bioorg Med Chem 6 1998 1089-1101
54. Y. Sumita H. Nouda K. Kanazawa M. Fukasawa Antimicrobial activity of SM-17466, a novel carbapenem antibiotic with potent activity against methicillin-resistant Staphylococcus aureus Antimicrob Agents Chemother 39 1995 910-916
55. Y. Ueda M. Sunagawa In vitro and in vivo activities of novel 2-(thiazol-2-ylthio)-1beta-methylcarbapenems with potent activities against multiresistant gram-positive bacteria Antimicrob Agents Chemother 47 2003 2471-2480
56. Fukuoka T, Koga T, Ishii C, Kitayama A, Namba E, Abe T, Nakagawa M, Matsushita Y, Shibayama T, Hirota T et al.: CS-023 (R-115685), a novel parenteral carbapenem: II. In vitro and in vivo activities against methicillin-resistant Staphylococcus aureus. 41st Interscience Conference of Antimicrobial Agents and Chemotherapy, September 22-25 2001; Chicago. [Abstract number F-366].
57. R. Nagano K. Shibata T. Naito A. Fuse K. Asano T. Hashizume S. Nakagawa Therapeutic efficacy of BO-3482, a novel dithiocarbamate carbapenem, in mice infected with methicillin-resistant Staphylococcus aureus Antimicrob Agents Chemother 41 1997 2278-2281
58. G.R. Lankas J.B. Coleman H.J. Klein Y. Bailly Species specificity of 2-aryl carbapenem-induced immune-mediated hemolytic anemia in primates Toxicology 108 1996 207-215
59. Rennecke J, Hirota T, Shibayama T, Matsushita Y, Kuwahara S, Puechler K, Ruhland A, Drewelow B: Safety, tolerability, and pharmacokinetics (PK) of CS-023, a new parenteral carbapenem, in healthy male volunteers. 42nd Interscience Conference of Antimicrobial Agents and Chemotherapy, September 27-30 2002; San Diego. [Abstract number F-327].
60. A. Schmitt-Hoffmann L. Nyman B. Roos M. Schleimer J. Sauer N. Nashed T. Brown A. Man E. Weidekamm Multiple-dose pharmacokinetics and safety of a novel broad-spectrum cephalosporin (BAL5788) in healthy volunteers Antimicrob Agents Chemother 48 2004 2576-2580
61. Y. Katayama H.Z. Zhang H.F. Chambers PBP 2a mutations producing very-high-level resistance to beta-lactams Antimicrob Agents Chemother 48 2004 453-459
62. Y. Utsui S. Ohya T. Magaribuchi M. Tajima T. Yokota Antibacterial activity of cefmetazole alone and in combination with fosfomycin against methicillin-and cephem-resistant Staphylococcus aureus Antimicrob Agents Chemother 30 1986 917-922
63. C. Fuda M. Suvorov S.B. Vakulenko S. Mobashery The basis for resistance to β-lactam antibiotics by penicillin-binding protein 2a of methicillin-resistant Staphylococcus aureus J Biol Chem 279 2004 40802-40806
64. A. Zervosen W.P. Lu Z. Chen R.E. White T.P. Demuth Jr. J.M. Frere Interactions between penicillin-binding proteins (PBPs) and two novel classes of PBP inhibitors, arylalkylidene rhodanines and arylalkylidene iminothiazolidin-4-ones Antimicrob Agents Chemother 48 2004 961-969
65. B. Fantin J. Pierre N. Castela-Papin L. Saint-Julien H. Drugeon R. Farinotti C. Carbon Importance of penicillinase production for activity of penicillin alone or in combination with sulbactam in experimental endocarditis due to methicillin-resistant Staphylococcus aureus Antimicrob Agents Chemother 40 1996 1219-1224
66. R.G. Washburn D.T. Durack Efficacy of ampicillin plus a beta-lactamase inhibitor (CP-45,899) in experimental endocarditis due to Staphylococcus aureus J Infect Dis 144 1981 237-243
67. H.F. Chambers M. Sachdeva S. Kennedy Binding affinity for penicillin-binding protein 2a correlates with in vivo activity of beta-lactam antibiotics against methicillin-resistant Staphylococcus aureus J Infect Dis 162 1990 705-710
68. L. Cantoni A. Wenger M.P. Glauser J. Bille Comparative efficacy of amoxicillin-clavulanate, cloxacillin, and vancomycin against methicillin-sensitive and methicillin-resistant Staphylococcus aureus endocarditis in rats J Infect Dis 159 1989 989-993
69. K. Miller C. Storey W.J. Stubbings A.M. Hoyle J.K. Hobbs I. Chopra Antistaphylococcal activity of the novel cephalosporin CB-181963 (CAB-175) J Antimicrob Chemother 55 2005 579-582
70. K. Shibata R. Nagano T. Hashizume H. Morishima Therapeutic efficacy of J-111,225, a novel trans-3,5-disubstituted pyrrolidinylthio-1beta-methylcarbapenem, against experimental murine systemic infections J Antimicrob Chemother 45 2000 379-382
71. Mandell, Douglas and Bennett's Principles and Practice of Infectious Diseases, Vol I and II, edn 6. Edited by Mandell GL, Bennett JE and Dolin R. Elsevier; 2004 2321-2351